Jonathan Biller
Treasurer at JUNO THERAPEUTICS INC
Net worth: 7 M $ as of 30/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jurg Oehen | M | 58 |
Celgene UK Manufacturing Ltd.
 Celgene UK Manufacturing Ltd. Financial ConglomeratesFinance Part of Bristol Myers Squibb Co., Celgene UK Manufacturing Ltd. functions as an investment holding private company. The company is based in London, UK.
Celgene Ltd.
 Celgene Ltd. Pharmaceuticals: MajorHealth Technology Celgene Ltd. engages in the development of human pharmaceuticals and agrochemicals. It focuses on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions. The company was founded on June 2, 2015 and is headquartered in Uxbridge, the United Kingdom.
Celgene UK Holdings Ltd.
 Celgene UK Holdings Ltd. Financial ConglomeratesFinance Part of Bristol Myers Squibb Co., Celgene UK Holdings Ltd. functions as an investment holding private company. The company is based in London, UK.
Celgene Europe Ltd.
 Celgene Europe Ltd. BiotechnologyHealth Technology Part of Bristol Myers Squibb Co., Celgene Europe Ltd. is a British company that engages in research and development in pharmaceutical products. The private company is based in Middlesex, UK.
Celgene UK Manufacturing (II) Ltd.
 Celgene UK Manufacturing (II) Ltd. Financial ConglomeratesFinance Part of Bristol Myers Squibb Co., Celgene UK Manufacturing (II) Ltd. functions as an investment holding private company. The company is based in London, UK. | 14 years |
| Jeffrey Leiden | M | 68 | 15 years | |
| Nakisa Serry | F | 59 |
Celgene Ltd.
Celgene Ltd. Pharmaceuticals: MajorHealth Technology Celgene Ltd. engages in the development of human pharmaceuticals and agrochemicals. It focuses on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions. The company was founded on June 2, 2015 and is headquartered in Uxbridge, the United Kingdom.
Celgene UK Holdings Ltd.
Celgene UK Holdings Ltd. Financial ConglomeratesFinance Part of Bristol Myers Squibb Co., Celgene UK Holdings Ltd. functions as an investment holding private company. The company is based in London, UK.
Celgene UK Manufacturing (II) Ltd.
Celgene UK Manufacturing (II) Ltd. Financial ConglomeratesFinance Part of Bristol Myers Squibb Co., Celgene UK Manufacturing (II) Ltd. functions as an investment holding private company. The company is based in London, UK.
Celgene Europe Ltd.
Celgene Europe Ltd. BiotechnologyHealth Technology Part of Bristol Myers Squibb Co., Celgene Europe Ltd. is a British company that engages in research and development in pharmaceutical products. The private company is based in Middlesex, UK.
Celgene UK Manufacturing Ltd.
Celgene UK Manufacturing Ltd. Financial ConglomeratesFinance Part of Bristol Myers Squibb Co., Celgene UK Manufacturing Ltd. functions as an investment holding private company. The company is based in London, UK. | 8 years |
| Reshma Kewalramani | M | 51 | 7 years | |
| Peter Kellogg | M | 67 | 6 years | |
| David Elkins | M | 55 | 6 years | |
| Stuart Arbuckle | M | 58 | 12 years | |
| Diana McKenzie | F | 59 | 4 years | |
| Carmen Bozic | M | 61 | 5 years | |
| Rahul Ballal | M | 46 | 2 years | |
| Nancy Thornberry | F | 67 | 1 years | |
| Alan Garber | M | 68 | 7 years | |
| Sarah Gheuens | M | 45 | 5 years | |
| Cynthia Smith | F | 55 | 2 years | |
| Suketu Upadhyay | M | 55 | 2 years | |
| Joy Liu | F | - | 8 years | |
| Sangeeta Bhatia | M | 55 | 9 years | |
| Lloyd Carney | M | 62 | 5 years | |
| Brian Goff | M | 55 | 2 years | |
| Kenneth Anderson | M | 72 |
Acetylon Pharmaceuticals, Inc.
 Acetylon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Acetylon Pharmaceuticals, Inc. develops pharmaceutical technology. It develops novel small molecule drugs which targets epigenetic mechanisms for the enhancement of therapeutic outcomes in cancer and other critical human diseases. The company was founded by Ralph Mazitschek, Kenneth C. Anderson, Marc A. Cohen, James E. Bradner, and Walter C. Ogier in October 2008 and is headquartered in Boston, MA. | 16 years |
| Mark Alles | M | 64 |
Acetylon Pharmaceuticals, Inc.
Acetylon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Acetylon Pharmaceuticals, Inc. develops pharmaceutical technology. It develops novel small molecule drugs which targets epigenetic mechanisms for the enhancement of therapeutic outcomes in cancer and other critical human diseases. The company was founded by Ralph Mazitschek, Kenneth C. Anderson, Marc A. Cohen, James E. Bradner, and Walter C. Ogier in October 2008 and is headquartered in Boston, MA. | - |
| Kristen Ambrose | F | 47 | 3 years | |
| Amit Sachdev | M | 56 | 17 years | |
| Bruce Sachs | M | 64 | 26 years | |
| Michel Lagarde | M | 50 | 1 years | |
| Edward Atkinson | M | 58 | 4 years | |
| Susie Lisa | F | - | 2 years | |
| Ann Li Lee | M | 63 | 6 years | |
| Mark Bunnage | M | - | 8 years | |
| Catherine Rutten | F | - | 4 years | |
| Nia Tatsis | M | 54 | 7 years | |
| Heather Nichols | F | - | - | |
| Samantha Ventimiglia | F | - | 13 years | |
| Mike Tirozzi | M | - | 5 years | |
| Charles Wagner | M | 55 | 5 years | |
| Ludovic Fenaux | M | - | 6 years | |
| Anne Patricia Janine Pellier | F | - |
Celgene Europe Ltd.
Celgene Europe Ltd. BiotechnologyHealth Technology Part of Bristol Myers Squibb Co., Celgene Europe Ltd. is a British company that engages in research and development in pharmaceutical products. The private company is based in Middlesex, UK. | - |
| Christopher Williams | M | - | - | |
| Manisha Pai | F | - | - | |
| Nina Devlin | F | - | 5 years | |
| Katherine Reynolds Kelly | F | 48 | - | |
| Nicole Keith | F | - | 9 years | |
| Elena A. Prokupets | M | - |
Acetylon Pharmaceuticals, Inc.
Acetylon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Acetylon Pharmaceuticals, Inc. develops pharmaceutical technology. It develops novel small molecule drugs which targets epigenetic mechanisms for the enhancement of therapeutic outcomes in cancer and other critical human diseases. The company was founded by Ralph Mazitschek, Kenneth C. Anderson, Marc A. Cohen, James E. Bradner, and Walter C. Ogier in October 2008 and is headquartered in Boston, MA. | - |
| Herman H. Vandenburgh | M | - |
Brown University
| 43 years |
| Stephanie Franklin | F | - | 7 years | |
| David Altshuler | M | 59 | 9 years | |
| Bruce Downey | M | 76 |
Acetylon Pharmaceuticals, Inc.
Acetylon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Acetylon Pharmaceuticals, Inc. develops pharmaceutical technology. It develops novel small molecule drugs which targets epigenetic mechanisms for the enhancement of therapeutic outcomes in cancer and other critical human diseases. The company was founded by Ralph Mazitschek, Kenneth C. Anderson, Marc A. Cohen, James E. Bradner, and Walter C. Ogier in October 2008 and is headquartered in Boston, MA. | - |
| Charlie Newman | F | - | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jacqualyn Fouse | M | 62 |
Bunge Ltd.
 Bunge Ltd. Agricultural Commodities/MillingProcess Industries Bunge Global SA operates as a holding company. engages in the supply and transportation of agricultural commodities. It operates through the following segments: Agribusiness, Refined and Specialty Oils, Milling, and Sugar and Bioenergy. The Agribusiness segment is involved in the purchase, storage, transportation, processing, and sale of agricultural commodities and commodity products. The Refined and Specialty Oils segment engages in the processing, production, and marketing of products derived from vegetable oils. The Milling segment consists of the processing, production, and marketing of products derived primarily from wheat and corn. The Sugar and Bioenergy segment includes the manufacture and marketing of sugar and ethanol derived from sugarcane, as well as energy derived from the sugar and ethanol production process. The company was founded by Johann Peter Gottlieb Bunge in 1818 and is headquartered in St. Louis, MO. | 10 years |
| Robert Hugin | M | 69 | 19 years | |
| Thomas Daniel | M | 69 | 10 years | |
| Timothy J. Smith | M | - | - | |
| Scott Smith | M | 61 | 10 years | |
| Jacquelyn Sumer | F | 46 | 1 years | |
| Thomas Perone | M | 59 | 12 years | |
| Scott Friend | M | 59 |
Brown University
| 4 years |
| Yuchun Lee | M | 58 | 11 years | |
| Rupert Vessey | M | 59 | 4 years | |
| Carrie Cox | F | 66 | 10 years | |
| Sandy Mahatme | M | 59 | 6 years | |
| Julia Haller | M | 69 | - | |
| Jeffrey Green | M | - |
Brown University
| 7 years |
| Gerald F. Masoudi | M | 56 | 3 years | |
| Jay Backstrom | M | 69 | 11 years | |
| Terrence Kearney | M | 69 | 13 years | |
| Tarek Galal Shawki Ahmed Shawki | M | 66 |
Brown University
| 3 years |
| Michael Bonney | M | 65 | 4 years | |
| Margaret McGlynn | F | 64 | 12 years | |
| Darrin Miles | M | - | 6 years | |
| Perry Karsen | M | 69 | 3 years | |
| Robert Hershberg | M | 61 | 5 years | |
| Lawrence V. Stein | M | 74 | 3 years | |
| Rodman L. Drake | M | 80 | 8 years | |
| Ian Clark | M | 62 | 6 years | |
| Brendan Delaney | M | 49 | 6 years | |
| Patricia Hemingway Hall | F | 71 | 1 years | |
| John Weiland | M | 68 | 1 years | |
| Richard Morgan | M | 79 | 29 years | |
| Gilla Kaplan | M | 76 | 20 years | |
| William Rastetter | M | 76 | 6 years | |
| Richard W. Barker | M | 75 | 7 years | |
| William Goltsos | M | - |
Brown University
| 5 years |
| Robert R. Baron | M | - |
Brown University
| 4 years |
| James Bandler | M | - |
Brown University
| 5 years |
| Tracey Navin Ewing | F | - |
Brown University
| 4 years |
| Steven Price | M | 62 |
Brown University
| 4 years |
| Thomas C. Downs | M | - |
Brown University
| 4 years |
| Joanne Jaffin Mason | F | - |
Brown University
| 4 years |
| Peter Kevin Poli | M | 63 |
Brown University
| 4 years |
| Brian Walsh | M | - |
Brown University
| 4 years |
| Steven Pickhardt | M | - |
Brown University
| 4 years |
| Janet Dillione | F | 65 |
Brown University
| 4 years |
| David M. Thomas | M | - |
Brown University
| 4 years |
| Tom Maloney | M | - |
Brown University
| 4 years |
| Craig Eder Moffett | M | - |
Brown University
| 4 years |
| John R. Borzilleri | M | - |
Brown University
| 4 years |
| Gregory Scott Markel | M | - |
Brown University
| 4 years |
| Scott P. Bruder | M | 62 |
Brown University
| 4 years |
| Robert Marcus | M | 58 |
Brown University
| 4 years |
| Nabil M. Lawandy | M | - |
Brown University
| 18 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 97 | 97.00% |
| United Kingdom | 3 | 3.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jonathan Biller
- Personal Network